Match tier
Listed
Presence
Current · Arkansas
Last published
2025
Sources
OpenAlex · ORCID
Refreshed
2026-08-08
V
Vijay Patel
Assistant Professor
Faculty Researcher
Pathology, College of Medicine
2 h-index
57 pubs
18 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Vijay Patel's research focuses on the molecular mechanisms of cancer, particularly in lymphomas and non-small-cell lung carcinoma. He has investigated NEK2 as a therapeutic target and regulator of oncogenic pathways in lymphoma, as detailed in his 2023 publication. His work also includes case reports and reviews of rare presentations of hematologic malignancies, such as large B-cell lymphoma presenting as primary central nervous system lymphoma and subcutaneous panniculitis-like T-cell lymphoma in pediatric patients. Patel collaborates extensively with colleagues at the University of Arkansas for Medical Sciences, including Kennith Swafford, Claire Doshier, Mason McCrury, and Sydnye L. Shuttleworth, with whom he shares a significant number of publications.
Metrics
- h-index: 2
- Publications: 57
- Citations: 18
Selected Publications
-
Large B-cell Lymphoma With Interferon Regulatory Factor 4 Rearrangement Presenting as a Primary Central Nervous System Lymphoma in the Brain (2025)
-
Subcutaneous Panniculitis‐Like T‐Cell Lymphoma Presenting as a Targetoid Plaque in a Pediatric Patient: A Case Report and Review of Literature (2025)
Collaboration Network
Top Collaborators
Mason McCrury
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Kennith Swafford
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Sydnye L. Shuttleworth
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Syed Hassan Mehdi
University of Arkansas Medical Center
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Baku Acharya
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Debasmita Saha
University of Arkansas for Medical Sciences (US)
1 shared publication
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Kevin Naceanceno
University of Arkansas for Medical Sciences (US)
1 shared publication
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Stephanie D. Byrum
Arkansas Children's Hospital
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Aaron J. Storey
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Ying-Zhi Xu
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Claire Doshier
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Ginell R. Post
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Annick De Loose
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Analiz Rodriguez
University of Arkansas for Medical Sciences
1 shared publication
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Leonard D. Shultz
Jackson Laboratory (US)
1 shared publication
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Similar Researchers
Based on overlapping research topics
Kennith Swafford
University of Arkansas for Medical Sciences
Lymphoma Diagnosis and Treatment
Cancer-related molecular mechanisms research
Disease Mechanisms Research
Akash Saha
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Disease Mechanisms Research
Receptor Mechanisms and Signaling
Claire Doshier
University of Arkansas for Medical Sciences
Lymphoma Diagnosis and Treatment
Cancer-related molecular mechanisms research
Disease Mechanisms Research
Thanh Ha Vy Nguyen
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Disease Mechanisms Research
Receptor Mechanisms and Signaling
Derek Middleton
University of Arkansas for Medical Sciences
Lymphoma Diagnosis and Treatment
Medical Case Reports
Disease Mechanisms Research
Trent R. Percy
University of Arkansas – Fort Smith
Cancer-related molecular mechanisms research
Disease Mechanisms Research
Receptor Mechanisms and Signaling